Ms Eva Christine Ida Woelders
Radboud University Medical Centre, Nijmegen (Netherlands (The))
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Complex versus non-complex, should we adjust the antiplatelet strategy to the type of percutaneous coronary intervention? Results from a real world PCI population
Event: ESC Congress 2024
Topic: Outcome
Session: The guardians of clotting: exploring antiplatelet strategies
Undiagnosed Diabetes Mellitus is an important risk factor in secondary prevention after an acute coronary syndrome and warrants active screening
Event: ESC Congress 2024
Topic: Prevention
Session: Advancing cardiac care in acute coronary syndromes: from genetics to social determinants
Lipid lowering treatment after percutaneous coronary intervention: data from the large contemporary ZON-HR registry.
Event: ESC Congress 2023
Topic: Primary Percutaneous Coronary Intervention (PCI)
Session: Beyond antithrombotic therapies in PCI: role of lipids, inflammation, and therapies on the horizon
Parsimonious versus extensive score: can we simplify bleeding risk stratification after percutaneous coronary intervention without losing specificity?
Event: ESC Congress 2023
Topic: Outcome
Session: Renal failure and bleeding in PCI patients
High bleeding risk mainly predicts non-access site bleeding events in the first month after percutaneous coronary intervention
Event: ESC Congress 2023
Topic: Outcome
Session: Renal failure and bleeding in PCI patients
The effect of P2Y12 inhibitor monotherapy according to bleeding risk: a systematic review and meta-analysis
Event: ESC Congress 2022
Topic: Pharmacotherapy
Session: Treatment of coronary artery disease
